Mining Online Heterogeneous Healthcare Networks for Drug Repositioning

Drug repositioning represents the application of known drugs for new indications and plays an important role in healthcare research and industry. With its increasing value in drug development, multiple approaches have been applied in its exercise, basically classified as drug-based and diseasebased approaches. Our study adopted a disease-based approach and utilized Adverse Drug Reactions (ADRs) as an intermediary to associate drugs with diseases for drug repositioning. Based on the collected health-related social media data, we constructed a heterogeneous healthcare network and developed three path-mining techniques to identify significant associations between ADRs and diseases and then determine the associations between potential drugs and diseases for repositioning. When an ADR has a strong association with a disease based on the drugs indicated for the disease, there is an underlying mechanism-of-action (MOA) between the disease and the ADR. The ADR can be considered as a clinical phenotypic biomarker of the disease. Others drugs that have a strong association with the ADR are prospective for repositioning [12]. The experiment results demonstrate the repositioning capability of the proposed method and the advantages of using social media data. The case studies and the ratio of supporting articles show its effectiveness and the potential for further drug development research.

[1]  Christopher C. Yang,et al.  Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media , 2014, TMIS.

[2]  Yan Li,et al.  Large-scale Direct Targeting for Drug Repositioning and Discovery , 2015, Scientific Reports.

[3]  Pankaj Agarwal,et al.  Systematic Drug Repositioning Based on Clinical Side-Effects , 2011, PloS one.

[4]  Jochen L. Leidner,et al.  Computational drug repositioning based on side-effects mined from social media , 2016, PeerJ Comput. Sci..

[5]  Jun S. Liu,et al.  Genetics of rheumatoid arthritis contributes to biology and drug discovery , 2013 .

[6]  Ping Zhang,et al.  Exploring the Relationship Between Drug Side-Effects and Therapeutic Indications , 2013, AMIA.

[7]  Christopher C. Yang,et al.  Expanding Consumer Health Vocabularies by Learning Consumer Health Expressions from Online Health Social Media , 2015, SBP.

[8]  A. Chiang,et al.  Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses , 2009, Clinical pharmacology and therapeutics.

[9]  Joel Dudley,et al.  Network-Based Elucidation of Human Disease Similarities Reveals Common Functional Modules Enriched for Pluripotent Drug Targets , 2010, PLoS Comput. Biol..

[10]  Chao Wu,et al.  Computational drug repositioning through heterogeneous network clustering , 2013, BMC Systems Biology.

[11]  Cheng Zhu,et al.  Drug repositioning for orphan diseases , 2011, Briefings Bioinform..

[12]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[13]  R. W. Hansen,et al.  The cost of drug development. , 2015, The New England journal of medicine.

[14]  Xin Wu,et al.  Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity. , 2014, Molecular bioSystems.

[15]  G. Lopez,et al.  Clinical approach to nonmotor sensory fluctuations in Parkinson's disease , 2011, Journal of the Neurological Sciences.

[16]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[17]  Xuning Tang,et al.  Detecting Signals of Adverse Drug Reactions from Health Consumer Contributed Content in Social Media , 2012 .

[18]  J. Jankovic,et al.  Pain in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[19]  William M. Campbell,et al.  Social Network Analysis with Content and Graphs , 2013 .

[20]  Philip E. Bourne,et al.  Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis , 2009, PLoS Comput. Biol..

[21]  Charu C. Aggarwal,et al.  Co-author Relationship Prediction in Heterogeneous Bibliographic Networks , 2011, 2011 International Conference on Advances in Social Networks Analysis and Mining.

[22]  Zhiyong Lu,et al.  Pathway-based drug repositioning using causal inference , 2013, BMC Bioinformatics.

[23]  Q. Zeng,et al.  Exploring and Developing Consumer Health Vocabularies , 2005 .

[24]  M. Namba,et al.  Transplantation of Melanocytes Obtained from the Skin Ameliorates Apomorphine-Induced Abnormal Behavior in Rodent Hemi-Parkinsonian Models , 2013, PloS one.

[25]  Steven J. M. Jones,et al.  Drug repositioning for personalized medicine , 2012, Genome Medicine.

[26]  Xiang Zhang,et al.  Drug repositioning by integrating target information through a heterogeneous network model , 2014, Bioinform..

[27]  F. Iorio,et al.  Transcriptional data: a new gateway to drug repositioning? , 2013, Drug discovery today.

[28]  Joel Dudley,et al.  Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..

[29]  Tae-Wan Kim,et al.  Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer’s Disease , 2014, Neurotherapeutics.

[30]  Christopher C. Yang,et al.  Using Health-Consumer-Contributed Data to Detect Adverse Drug Reactions by Association Mining with Temporal Analysis , 2015, ACM Trans. Intell. Syst. Technol..

[31]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[32]  Mingkun Jiao,et al.  Computational drug repositioning for cancer therapeutics. , 2015, Current topics in medicinal chemistry.

[33]  Zhiyong Lu,et al.  A new method for computational drug repositioning using drug pairwise similarity , 2012, 2012 IEEE International Conference on Bioinformatics and Biomedicine.

[34]  Philip E. Bourne,et al.  Anti-Infectious Drug Repurposing Using an Integrated Chemical Genomics and Structural Systems Biology Approach , 2013, Pacific Symposium on Biocomputing.

[35]  J. Kwon,et al.  Abnormal corticostriatal-limbic functional connectivity in obsessive–compulsive disorder during reward processing and resting-state☆ , 2013, NeuroImage: Clinical.

[36]  Noam Shomron,et al.  Pharmaco-miR: linking microRNAs and drug effects , 2013, Briefings Bioinform..

[37]  Ekaterina Rogaeva,et al.  Drug Repositioning for Diabetes Based on 'Omics' Data Mining , 2015, PloS one.

[38]  Cécile Paris,et al.  Text and Data Mining Techniques in Adverse Drug Reaction Detection , 2015, ACM Comput. Surv..

[39]  Ryen W. White,et al.  Web-scale pharmacovigilance: listening to signals from the crowd , 2013, J. Am. Medical Informatics Assoc..

[40]  Mingzhi Liao,et al.  Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses , 2012, Scientific Reports.